New weight loss drugs can cause decline in skeletal muscle mass: Study

Linking metabolic disorders to Alzheimer's disease: A comprehensive Study

The global rise in obesity and type 2 diabetes (T2D) has led to an increased focus on understanding the relationship between metabolic disorders and neurodegenerative diseases such as Alzheimer's disease (AD). The term Type 3 diabetes has been proposed to describe AD, given the significant overlap in risk, comorbidity, and pathophysiological pathways between T2D and AD. 27 days ago